% Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England © Copyright NHSBSA 2009.

Slides:



Advertisements
Similar presentations
Prof Graeme Henderson Department of Pharmacology C32 Medical Sciences Building Anticholinergics Opioids Benzodiazepines and.
Advertisements

Guy Brookes Leeds PFT.  Antipsychotic Medication  Antidepressant Medication  Mood Stabilisers  What does the Evidence mean?
% Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England.
DUR Board Meeting March 12, 2008 West Virginia Department of Health and Human Resources Bureau for Medical Services Drug Utilization Review Board.
The Right Prescription A Call to Action for junior doctors on the use of antipsychotic drugs for people with dementia.
PACKAGING OF MEDICINES AND CHILDREN SAFETY Accident data from Belgium Dr Martine MOSTIN.
Relative toxicity of traditional versus atypical antipsychotics in deliberate self poisoning M A Downes, G K Isbister, D Sibbritt, I M Whyte, A H Dawson.
Newer Psychotropic Medications David P. Kraft, MD, MPH Region I Mental Health Consultant Region 1 Health and Wellness Conference San Juan, Puerto Rico.
Chapter 3 Biological Basis for Understanding Psychiatric Disorders and Treatments Copyright © 2014, 2010, 2006 by Saunders, an imprint of Elsevier Inc.
General Management principles- Investigations & Treatment Modalities Dr Alok Rana Consultant Old Age Psychiatrist.
Trends in Usage of Non-Opioid Analgesics in General Practice in England © Copyright NHSBSA 2008.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 33 Drugs for Bipolar Disorder.
1 These slides should be used in conjunction with the accompanying notes Hypnotics.
Trends in Prescribing of and Spending on Digoxin in General Practice in England © Copyright NHSBSA 2009.
1 Deaths from antidepressants in England and Wales 1993 to 2000: analysis of a national database of drug-related poisoning deaths Allan Baker, UK Office.
Marcie Hall, M.D. Department of Child and Adolescent Psychiatry University Hospitals Case Medical Center Autism Summit October 10, 2008 Medication Use.
Psychopharmacology – A brief introduction. Objectives Review general categories of psychiatric disorders Review general categories of psychiatric disorders.
Bipolar I Disorder Treatment. Therapeutic Goals Relief of immediate symptoms Improvement of patient’s well-being Elimination of stressors Combined pharmacotherapy.
Trends in Spending on Selective Beta 2 Agonists in General Practice in England.
Pharmacological Management. Only symptomatic treatment, there is no cure. Acetylcholinesterase inhibitors - Only for mild to moderate dementia –Donepezil.
Use of Medication. Test review Stages of change Substance-related disorders: –know the difference between use and induced disorders –be able to describe.
+ Finding Balance: Preventing Medication Related Falls Through Appropriate Medication Use Chanel F. Agness, PharmD, Certified Geriatric Pharmacist
Trends in Prescribing of Selected Alpha-Blockers in General Practice in England © Copyright NHSBSA 2008.
Exhibit 25.1 Annual Percentage Changes in the Prescription Drug Price Index and Prescription Drug Expenditures, Copyright 2011 Health Administration.
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 22 Drugs Affecting the Central Nervous System.
Trends in Prescribing of Sodium Chloride Irrigation Solutions in General Practice in England © Copyright NHSBSA 2008.
Stuttering and Medications City of Chicago NSA Chapter March 26, 2015.
1 Governor’s Office of Health Policy and Finance MaineCare Pharmacy Initiatives.
PSYCHIATRIC DRUGS Chapter 13. Psychiatric Drugs  Treat mood, cognition, and behavioral disturbances associated with psychological disorders  Psychotropic.
Drugs Used in Autism and Other Neurological diseases.
Risk of Serious Cardiac Events in Older Adults Using Antipsychotic Agents Sandhya Mehta, MS; Hua Chen, MD, PhD; Michael Johnson, PhD; and Rajender R. Aparasu,
Treating Mental Illness Bittu Majmudar September 25, 2007 Neuroethics.
Pie Chart Showing the Breakdown of Gastro-intestinal Prescribing in General Practice in England (July June 2008 ) © Copyright NHSBSA 2008.
Practice pharmacology, medical students III.yr. November 2013
Psychotropic Medication Management on Center David P. Kraft, MD, MPH Region I Mental Health Consultant National Health and Wellness Conference Orlando,
Variations in anxiolytic and hypnotic prescribing by GPs: a cross-sectional analysis using data from the UK Quality and Outcomes Framework by Zoi Tsimtsiou,
Trends in Spending on Selective Beta 2 Agonists in General Practice in England © Copyright NHSBSA 2009.
Psychiatric Medications: Interactions Chitra Malur MD Asst. Chief of Service Dept. of Psychiatry UMDNJ.
The Latest Prescription Trends for Controlled Prescription Drugs
Prescribing in Dementia. Plan What to prescribe? When to prescribe? How to review? Who to review?
Inside Maine’s Medicine Cabinet. Inside Maine’s Medicine Cabinet: Analysis of the Maine Prescription Monitoring Program, Christina Holt, MD,
John Tsuang, M.D., M.S. Associate Clinical Professor Department of Psychiatry, University of California Los Angeles Director of Dual Diagnostic Treatment.
Drug interactions in dementia Stephen Bleakley Locality Lead Pharmacist November 2010
Drugs Used in Autism and Other Neurological diseases Dr. Yieldez Bassiouni.
INTRODUCTORY MENTAL HEALTH NURSING Donna M. Womble 2005.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Comparative Mortality Risk in Adult Patients With.
1 Future Spending for Prescription Drugs Used for Mental Health and Substance Use Disorders: Does the Past Portend the Future? Linda Simoni-Wastila, RPh,
Quetiapine Fumarate Quetiapine Fumarate is an atypical antipsychotic used in the treatment of schizophrenia, bipolar I mania, bipolar II depression, bipolar.
Pharmacological management of delirium
Psychopharmacology of Autism Spectrum Disorder
Dementia and Medication Considerations
Ch. 13: Biomedical Therapy: Biological Approaches to Treatment
Efforts to Reduce Antipsychotic Use in Dementia Care are Starting to Bear Fruit, but a Lot of Work Remains to be Done  M. Susan Macaulay, BA  Journal.
Receptor occupancy and clinical response for antipsychotic agents
Copyright © 2005 American Medical Association. All rights reserved.
Date of preparation March 2010
Barbiturates Meprobamate Paralehyde Chloral hydrate
Brief Overview of Common Psychotropic Medications --and--
GROUPS.
Drugs for Bipolar Disorder
Medication Effects That May Impair Driving Ability
Antipsychotic Agents and Their Use in Schizophrenia
Chapter 3 Biological Basis for Understanding Psychiatric Disorders and Treatments.
Drug-induced dyskinesias
CHAPTER 21 Drugs and other physical treatments
Polypharmacy Pharmacist Consultant Liz Butterfield FRPharmS
Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study  Katherine Donegan,
Depression in the Elderly
by Zoi Tsimtsiou, Mark Ashworth, and Roger Jones
Dr James Ovens Consultant Psychiatrist Tandridge CMHRS
Presentation transcript:

% Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England © Copyright NHSBSA 2009

% Ratio of Spending on Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Hypnotics in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Hypnotics in General Practice in England © Copyright NHSBSA 2009

Quantities of "Z" drugs (Zaleplon, Zolpidem & Zopiclone) Prescribed in General Practice in England (Quarter to December 2008) © Copyright NHSBSA 2009

Quantities of Selected Hypnotics (Tabs/Caps) Prescribed in General Practice in England (Quarter to December 2008) © Copyright NHSBSA 2009

% of Prescriptions for Selected Hypnotics (Tabs/Caps) in General Practice in England for Defined Quantities (Quarter to December 2008) © Copyright NHSBSA 2009

Trends in Prescribing of Anxiolytics in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Anxiolytics in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Antipsychotic Drugs (BNF 4.2.1) in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Antipsychotic Drugs (BNF 4.2.1) in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of "Typical" Antipsychotics in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on "Typical" Antipsychotics in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of "Atypical" Antipsychotics in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on "Atypical" Antipsychotics in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of and Spending on Aripiprazole in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Olanzapine Tablets by Strength in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Quetiapine by Strength in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Risperidone Tablets by Strength in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of and Spending on Valproic Acid (Depakote®) in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of and Spending on Lithium in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Antidepressants in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Antidepressants in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Tricyclic and related antidepressants in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Tricyclic and related antidepressants in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of SSRIs in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on SSRIs in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Other Antidepressant drugs (BNF 4.3.4) in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Other Antidepressant drugs (BNF 4.3.4) in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of ADHD Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on ADHD Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Methylphenidate Preparations in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Methylphenidate Preparations in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Methadone in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Methadone in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Methadone (Excluding Liquid Formulations) in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Older Antiepileptic Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Older Antiepileptic Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Newer Antiepileptic Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Newer Antiepileptic Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Co-beneldopa and Co-careldopa in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Co-beneldopa and Co-careldopa in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Other Dopaminergic Drugs used in Parkinsonism in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Other Dopaminergic Drugs used in Parkinsonism in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Antimuscarinic Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Antimuscarinic Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of and Spending on Buprenorphine and Buprenorphine / Naloxone(BNF 4.10 Opioid Dependence) in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of and Spending on Lofexidine in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of and Spending on Naltrexone in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Drugs for Dementia in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Drugs for Dementia in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Melatonin in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Melatonin in General Practice in England © Copyright NHSBSA 2009

Trends in Instalment Dispensing Forms in General Practice in England © Copyright NHSBSA 2009